4.8 Article

Targeting CK2-mediated phosphorylation of p53R2 sensitizes BRCA-proficient cancer cells to PARP inhibitors

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

TOPORS-mediated RAD51 SUMOylation facilitates homologous recombination repair

Gurusamy Hariharasudhan et al.

Summary: SUMOylation of RAD51 is crucial for its recruitment to chromatin and HR repair. TOPORS-mediated RAD51 SUMOylation plays a key role in promoting HR repair and genomic maintenance.

NUCLEIC ACIDS RESEARCH (2022)

Article Oncology

Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function

Xixi Zhao et al.

Summary: This study reveals the role of CK2 in immunosuppression by phosphorylation and stabilization of PD-L1, and suggests CK2 inhibition as a potential immunotherapeutic approach for treating cancer.

CANCER RESEARCH (2022)

Article Biochemistry & Molecular Biology

Validation of an LC-MS/MS Method for the Quantification of the CK2 Inhibitor Silmitasertib (CX-4945) in Human Plasma

Rico Schwarz et al.

Summary: Silmitasertib is a drug currently being investigated in clinical trials for the treatment of various cancers. It inhibits CK2 protein kinase, which has proliferation-promoting and anti-apoptotic effects on cancer cells. Researchers have developed an LC-MS/MS method for quantifying silmitasertib in human plasma.

MOLECULES (2022)

Article Biochemistry & Molecular Biology

ZMYM2 restricts 53BP1 at DNA double-strand breaks to favor BRCA1 loading and homologous recombination

Doohyung Lee et al.

Summary: The inability to repair DNA double-strand breaks (DSBs) can lead to genome instability and human diseases, such as cancer. This study identifies zinc-finger proteins ZMYM2 and ZMYM3 as antagonizers of 53BP1 recruitment, which enhances the recruitment and function of HR proteins in DNA repair. Depletion of these proteins leads to genome instability, increased sensitivity to PARP inhibitors and ionizing radiation, and reduced HR repair.

NUCLEIC ACIDS RESEARCH (2022)

Article Cell Biology

ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells

Priyanka Verma et al.

Summary: This study identified ALC1/CHD1L as a key determinant of PARPi toxicity in HR-deficient cells, showing that loss of ALC1 reduces viability of cancer cells with BRCA mutations and increases sensitivity to PARPi. ALC1 deficiency decreases chromatin accessibility, leading to accumulation of DNA damage, enhanced PARP trapping, and reliance on HR repair mechanisms. These findings highlight the importance of PAR-dependent chromatin remodeling as a therapeutic target in HR-deficient cancers.

NATURE CELL BIOLOGY (2021)

Review Biochemistry & Molecular Biology

BRCA Mutations in Prostate Cancer: Assessment, Implications and Treatment Considerations

Sidrah Shah et al.

Summary: Prostate cancer ranks fifth in cancer-related mortality in men worldwide, and DNA damage is implicated in its pathogenesis. Impaired DDR pathways play a role in prostate carcinogenesis, with germline or somatic mutations in DDR genes being found in primary and metastatic prostate cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Genetics & Heredity

Homologous Recombination as a Fundamental Genome Surveillance Mechanism during DNA Replication

Julian Spies et al.

Summary: Accurate and complete genome replication is vital for genetic transfer, cell growth, and stability, but replication stress (RS) is a hallmark of cancer, with cells deploying mechanisms like homologous recombination (HR) to safeguard replicating genomes. Cancer cells exploit these responses to evolve and resist therapy, with DSG repair being naturally silenced in pathophysiological scenarios, fueling mutagenesis and adaptive responses that can be targeted for therapy.

GENES (2021)

Article Cell Biology

Targeting CK2 in cancer: a valuable strategy or a waste of time?

Mauro Salvi et al.

Summary: The newly developed compound SGC-CK2-1, which is more selective than other CK2 inhibitors, has shown poor efficacy in reducing cell growth in different cancer cell lines, raising questions about the anticancer efficacy of CX-4945, the commonly used clinical-grade CK2 inhibitor.

CELL DEATH DISCOVERY (2021)

Review Genetics & Heredity

PARP1: Structural insights and pharmacological targets for inhibition

Jacob O. Spiegel et al.

Summary: PARP1 is a multifunctional enzyme involved in DNA repair pathways. Pharmacological inhibition of PARP1 is used to treat certain cancers, but resistance is common, highlighting the need for novel therapeutic approaches.

DNA REPAIR (2021)

Article Biochemistry & Molecular Biology

XRCC1 prevents toxic PARP1 trapping during DNA base excision repair

Annie A. Demin et al.

Summary: PARPs and XRCC1 accelerate mammalian DNA base excision repair (BER), where XRCC1 prevents excessive PARP1 engagement during BER and traps PARP1 on BER intermediates. Excessive PARP1 engagement poses a threat to genome integrity, while XRCC1 acts as an anti-trapper preventing toxic PARP1 activity. Deletion of PARP1 rescues BER and resistance to base damage in XRCC1-deficient cells.

MOLECULAR CELL (2021)

Article Oncology

mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer

Ling Tian et al.

Summary: mTORC2 plays a key role in gemcitabine resistance in non-small cell lung cancers, enhancing cytotoxicity and DNA damage induced by gemcitabine. It interacts with and phosphorylates RNR large subunit RRM1 at Ser 631, leading to increased RNR activity for efficient DNA replication. Targeting mTORC2 slows down DNA replication fork progression and improves the therapeutic efficacy of gemcitabine in NSCLC xenograft model.

NEOPLASIA (2021)

Article Multidisciplinary Sciences

Structural basis for allosteric PARP-1 retention on DNA breaks

Levani Zandarashvili et al.

SCIENCE (2020)

Review Cell Biology

The molecular basis and disease relevance of non-homologous DNA end joining

Bailin Zhao et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

CK2 kinase-mediated PHF8 phosphorylation controls TopBP1 stability to regulate DNA replication

Haihua Feng et al.

NUCLEIC ACIDS RESEARCH (2020)

Review Medical Laboratory Technology

BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies

Anbok Lee et al.

ANNALS OF LABORATORY MEDICINE (2020)

Review Cell Biology

DNA double-strand break repair-pathway choice in somatic mammalian cells

Ralph Scully et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Article Medicine, Research & Experimental

Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy

Guo Chen et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Biochemistry & Molecular Biology

ZNF830 mediates cancer chemoresistance through promoting homologous-recombination repair

Guo Chen et al.

NUCLEIC ACIDS RESEARCH (2018)

Review Biochemistry & Molecular Biology

Insights into the biogenesis, function, and regulation of ADP-ribosylation

Michael S. Cohen et al.

NATURE CHEMICAL BIOLOGY (2018)

Article Genetics & Heredity

Mechanisms of PARP inhibitor sensitivity and resistance

Alan D. D'Andrea

DNA REPAIR (2018)

Article Biochemistry & Molecular Biology

Ribonucleotide Reductase Requires Subunit Switching in Hypoxia to Maintain DNA Replication

Iosifina P. Foskolou et al.

MOLECULAR CELL (2017)

Article Biochemistry & Molecular Biology

MRE11 stability is regulated by CK2-dependent interaction with R2TP complex

P. von Morgen et al.

ONCOGENE (2017)

Review Multidisciplinary Sciences

PARP inhibitors: Synthetic lethality in the clinic

Christopher J. Lord et al.

SCIENCE (2017)

Review Cell Biology

Repair Pathway Choices and Consequences at the Double-Strand Break

Raphael Ceccaldi et al.

TRENDS IN CELL BIOLOGY (2016)

Article Biochemistry & Molecular Biology

Disruption of PARP1 function inhibits base excision repair of a sub-set of DNA lesions

Pamela Reynolds et al.

NUCLEIC ACIDS RESEARCH (2015)

Article Biochemistry & Molecular Biology

APC/CCdh1 controls CtIP stability during the cell cycle and in response to DNA damage

Lorenzo Lafranchi et al.

EMBO JOURNAL (2014)

Article Multidisciplinary Sciences

RNA-Guided Human Genome Engineering via Cas9

Prashant Mali et al.

SCIENCE (2013)

Article Biochemistry & Molecular Biology

Protein kinase CK2 localizes to sites of DNA double-strand break regulating the cellular response to DNA damage

Birgitte B. Olsen et al.

BMC MOLECULAR BIOLOGY (2012)

Article Multidisciplinary Sciences

Mammalian ribonucleotide reductase subunit p53R2 is required for mitochondrial DNA replication and DNA repair in quiescent cells

Giovanna Pontarin et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Biochemistry & Molecular Biology

53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers

Peter Bouwman et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)

Article Biochemistry & Molecular Biology

CK2 phosphorylation-dependent interaction between aprataxin and MDC1 in the DNA damage response

Olivier J. Becherel et al.

NUCLEIC ACIDS RESEARCH (2010)

Article Oncology

Use of γH2AX and Other Biomarkers of Double-Strand Breaks During Radiotherapy

Ali Sak et al.

SEMINARS IN RADIATION ONCOLOGY (2010)

Article Biochemistry & Molecular Biology

p53R2-dependent ribonucleotide reduction provides Deoxyribonucleotides in quiescent human fibroblasts in the absence of induced DNA damage

Giovanna Pontarin et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Biochemistry & Molecular Biology

The protein kinase CK2 facilitates repair of chromosomal DNA single-strand breaks

JI Loizou et al.